Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
21-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #63477
advertisement
Omodaka K
23
Showing records 1 to 23 |
Display all abstracts from
Omodaka K
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Sato K
Experimental Eye Research
2020; 193: 107997
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kiyota N
Acta Ophthalmologica
2020; 98: e747-e753
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Omodaka K; Fujioka S
Current Eye Research
2020; 45: 1302-1308
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Shiga Y
Acta Ophthalmologica
2020; 98: e747-e753
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Mochida S
Experimental Eye Research
2020; 193: 107997
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Yasuda M
Acta Ophthalmologica
2020; 98: e747-e753
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
An G
Current Eye Research
2020; 45: 1302-1308
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tomimoto D
Experimental Eye Research
2020; 193: 107997
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Udagawa T
Current Eye Research
2020; 45: 1302-1308
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Aizawa N
Acta Ophthalmologica
2020; 98: e747-e753
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Konuma T; Kiyota N
Experimental Eye Research
2020; 193: 107997
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Tsuda S
Current Eye Research
2020; 45: 1302-1308
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Omodaka K; Tsuda S
Acta Ophthalmologica
2020; 98: e747-e753
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Tsuda S
Experimental Eye Research
2020; 193: 107997
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Shiga Y; Morishita S
Current Eye Research
2020; 45: 1302-1308
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Shiga Y
Experimental Eye Research
2020; 193: 107997
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Pak K
Acta Ophthalmologica
2020; 98: e747-e753
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Kikawa T
Current Eye Research
2020; 45: 1302-1308
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Omodaka K
Experimental Eye Research
2020; 193: 107997
86141
The optic nerve head vasoreactive response to systemic hyperoxia and visual field defect progression in open-angle glaucoma, a pilot study
Kunikata H; Nakazawa T
Acta Ophthalmologica
2020; 98: e747-e753
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Pak K
Current Eye Research
2020; 45: 1302-1308
86417
A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
Nakazawa T
Experimental Eye Research
2020; 193: 107997
86341
Structural Characterization of Glaucoma Patients with Low Ocular Blood Flow
Akiba M; Yokota H; Nakazawa T
Current Eye Research
2020; 45: 1302-1308
Issue
21-2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-2 (2024)
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement